330726P
Avanti
C13-dihydroceramide-d7(d18:0-d7/13:0)
Avanti Polar Lipids
Synonym(s):
N-tridecanoyl-D-erythro-sphinganine-d7
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Assay
99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (330726P-1MG)
manufacturer/tradename
Avanti Polar Lipids
shipped in
dry ice
storage temp.
−20°C
General description
C13-dihydroceramide-d7 (d18:0-d7/13:0) is a deuterated derivative of C13-dihydroceramide.
Biochem/physiol Actions
Dihydroceramide is involved in the regulation of autophagy, hypoxia and cell proliferation.
Packaging
5 mL Amber Glass Screw Cap Vial
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Dihydroceramides: from bit players to lead actors
Test, 290(25), 15371-15379 (2015)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service